RecallRadar

FDA Drug recall D-1178-2022

Enalapril Maleate Tablets, USP

On 2022-07-13 the FDA classified a Class II recall of Enalapril Maleate Tablets, USP by Golden State Medical Supply, citing CGMP Deviations.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-1178-2022
ClassificationClass II
Statusongoing
Initiated2022-03-16
Published2022-07-13
Last updated2026-09-13 11:52 UTC
CompanyGolden State Medical Supply
DistributionUS

Product

Enalapril Maleate Tablets, USP; 5 mg; 90 tablets, NDC 60429-184-90; manufactured by Taro Pharmaceutical Industries, Ltd.; packaged by GSMS, Incorporated, CA.

Reason

CGMP Deviations

Identifiers

ndc60429-183-30
ndc60429-183-10
ndc60429-183-90
ndc60429-184-30
ndc60429-184-10
ndc60429-184-90
ndc60429-185-30
ndc60429-185-10
ndc60429-185-90
ndc60429-186-30
ndc60429-186-10
ndc60429-186-90
code_info
Lot: GS029041, GS029353, GS02986, 5 mg; 90 tablets, Exp.: 09/2022; Lot: GS030056, GS030869, GS033943, Exp.: 10/2022; L…Lot: GS029041, GS029353, GS02986, 5 mg; 90 tablets, Exp.: 09/2022; Lot: GS030056, GS030869, GS033943, Exp.: 10/2022; Lots: GS034490, GS035197, Exp.:02/2023; Lots: GS035198, Exp.: 03/2023; Lots: GS035596, GS035947, GS036759, GS037400, Exp.: 06/2023; Lots: GS038089, GS038763, GS039559, GS040150, Exp.: 10/2023; Lots: GS040151, GS040708, GS041107, Exp.: 12/2023; Lot: GS041654, Exp.: 03/2024.

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1178-2022%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.